Quantcast

Neuronetrix Wins Contract to Measure Effects of Novel Cognitive Enhancer

December 19, 2013

Neuronetrix has been awarded a contract to evaluate a novel compound’s ability to enhance cognitive performance. Under the contract, Neuronetrix’s COGNISION™ System will be utilized by The Memory Clinic, Bennington, VT, to evaluate the pro-cognitive effects of Onnit Lab’s Alpha Brain™ supplement.

Louisville, KY (PRWEB) December 19, 2013

Neuronetrix has been awarded a contract to evaluate a novel compound’s ability to enhance cognitive performance. Under the contract, Neuronetrix’s COGNISION™ System will be utilized by The Memory Clinic, Bennington, VT, to evaluate the pro-cognitive effects of Onnit Lab’s Alpha Brain™ supplement.

“COGNISION™ was chosen due to its ability to provide the sensitive measures of pharmacodynamic effects necessary to validate Alpha Brain’s neuro enhancement properties,” said KC Fadem, CEO of Neuronetrix.

About COGNISION™

The COGNISION™ System is a proprietary neuro-electrophysiological device which provides objective assessments of cognitive function. COGNISION™ implements powerful and validated scientific methods in a practical, cost effect, and easy to use design.

About Neuronetrix

Neuronetrix, developer of the COGNISION™, is a leading neurotech company focused on providing physicians and scientists with accurate and meaningful information about brain processing. This information is critical in the understanding of complex brain function, diagnosis of cognitive disorders, and evaluating the effects of pro-cognitive therapies.

Information about Neuronetrix is available at http://www.neuronetrix.com or by contacting Daniel Lawson at dlawson(at)neuronetrix(dot)com, or (502) 561-9040, x7003.

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/12/prweb11429021.htm


Source: prweb



comments powered by Disqus